Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

38.41 -0.93 (-2.35%)
Streaming Delayed Price Updated: 9:58 AM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche
The companies both have drugs that treat relapsing forms of multiple sclerosis. 
Via Investor's Business Daily
Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher
TG Therapeutics has broken an important resistance level. There is a good chance that they will continue to move higher. 
Via Benzinga
How does TG THERAPEUTICS INC (NASDAQ:TGTX) stack up against Mark Minervini’s strategy?
A fundamental and technical analysis of (NASDAQ:TGTX): Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing? 
Via Chartmill
TG THERAPEUTICS INC (NASDAQ:TGTX), a growth stock which is not overvalued.
Uncover the potential of TG THERAPEUTICS INC, a growth stock reasonably priced. NASDAQ:TGTX is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive... 
Via Chartmill
Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio?
Top mid-cap stocks jumped up to 23.87%. Some reasons include strong gold/silver, better financial results, and market strength. 
Via Benzinga
Why TG Therapeutics Stock Was Soaring This Week
Via The Motley Fool
Expert Outlook: TG Therapeutics Through The Eyes Of 5 Analysts
Via Benzinga
TG Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week
Annual revenue from its MS drug, Briumvi, more than tripled, with U.S. net product revenue reaching $103.6 million in the fourth quarter and $310 million for the full year. 
Via Stocktwits
Stocks Pivot Lower On Trade Fears, Manufacturing Data
Despite earlier indicating a strong start to March, stocks are lower this afternoon amid trade war concerns. 
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide
The company has gained notoriety for its multiple sclerosis treatment. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Earnings Scheduled For March 3, 2025
Via Benzinga
A Closer Look at TG Therapeutics's Options Market Dynamics
Via Benzinga
NASDAQ:TGTX stands out as a growth opportunity that won't break the bank.
NASDAQ:TGTX is showing decent growth, but is still valued reasonably. 
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With TG Therapeutics Stock Tuesday?
TG Therapeutics Inc (NASDAQ:TGTX) shares are trading higher. The company on Tuesday provided guidance for the fourth quarter and full-year 2024. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
A Fed rate cut and a slew of big earnings reports filled out a busy week. 
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
The Analyst Verdict: TG Therapeutics In The Eyes Of 5 Experts
Via Benzinga
TG Therapeutics Crashes — Reversing A Breakout — On Its Mixed Third-Quarter Results
The company raised its sales outlook for the year, though, following stronger-than-expected revenue from its only product. 
Via Investor's Business Daily
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Napco Security Technologies Posts Downbeat Results, Joins Centrus Energy, Constellation Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
10 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Delving into NASDAQ:TGTX's Growth Prospects.
Why TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock. 
Via Chartmill
Why NASDAQ:TGTX qualifies as a high growth stock.
Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing? 
Via Chartmill
AI Stocks Meta, Oracle Lead Five Names Near Buy Points
Two of the 5 top stocks to watch this week tap the artificial intelligence market. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report
Amid the election, and a Fed rate vote, earnings season roars ahead. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
Investors seeking growth at a reasonable cost should explore NASDAQ:TGTX.
TG THERAPEUTICS INC (NASDAQ:TGTX) stands out as a growth opportunity that won't break the bank. 
Via Chartmill
NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
TG THERAPEUTICS INC (NASDAQ:TGTX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.